| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911027 | Lung Cancer | 2013 | 8 Pages |
Abstract
This study indicates that the combination of HDAC inhibitor VPA with CDK inhibitor P276-00 is promising novel molecularly targeted therapeutic approach for NSCLC treatment.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Nitesh Shirsath, Maggie Rathos, Umesh Chaudhari, H. Sivaramakrishnan, Kalpana Joshi,